SG/CALL/STRYKER CORP./320/0.1/17.01.25 Stock

Warrant

DE000SQ86376

Market Closed - Deutsche Boerse AG 15:46:42 2024-06-28 EDT
3.73 EUR -1.06% Intraday chart for SG/CALL/STRYKER CORP./320/0.1/17.01.25
Current month-2.10%
1 month-2.61%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-06-28 3.73 -1.06%
24-06-27 3.77 -0.26%
24-06-26 3.78 +4.42%
24-06-25 3.62 -2.69%
24-06-24 3.72 -5.58%

Delayed Quote Deutsche Boerse AG

Last update June 28, 2024 at 03:46 pm

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying STRYKER CORPORATION
IssuerLogo Issuer Société Générale Société Générale
WKN SQ8637
ISINDE000SQ86376
Date issued 2023-02-16
Strike 320 $
Maturity 2025-01-17 (202 Days)
Parity 10 : 1
Emission price 2.77
Emission volume N/A
Settlement Barausgleich
Currency EUR

Technical Indicators

Highest since issue 5.82
Lowest since issue 1.19
Spread 0.05
Spread %1.30%

Company Profile

Stryker Corporation is one of the world's leaders in designing, manufacturing, and selling orthopedic equipments. Net sales break down by family of products as follows: - surgical equipments and neurotechnology products (57.5%): electric motorized surgical instruments, surgical navigation systems, endoscopy equipment, digital imaging systems, neurosurgery equipments, neurovascular devices, etc. The group also offers hospital beds, gurneys, stretchers, and emergency room equipment; - orthopedic implants (42.5%): joint prostheses, traumatology implants, micro-implants, orthopedic cement, orthobiology products, etc. The group also provides spinal implants. At the end of 2022, the group had 48 production sites worldwide. Net sales are distributed geographically as follows: the United States (73.9%), Europe/Middle East/Africa (12.7%), Asia/Pacific (10.2%) and other (3.2%).
Sector
-
More about the company

Ratings for Stryker Corporation

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Consensus: Stryker Corporation

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
340.2 USD
Average target price
372.9 USD
Spread / Average Target
+9.61%
Consensus